2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…2015 American Transplant Congress
Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients
Surgery, The Ohio State University, Columbus, OH.
The present study evaluated the outcome of a Sirolimus based maintenance immunosuppressive protocol in pancreas transplant recipients. Between August 2003 and December 2013, a total…2015 American Transplant Congress
Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients
Surgery, Multi-Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.
Background: A once-daily, modified-release oral formulation of tacrolimus has been developed to simplify dosing and improve medication adherence. There is limited data on the implementation…2015 American Transplant Congress
Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)
Background:Shortage of optimal pancreatic donors stimulates a search for options to expand the donor pool. Extreme age donors ( <13 yrs or > 50 yrs…2015 American Transplant Congress
Import Pancreas Transplants: Good from Far or Far from Good?
General Surgery-Transplantation, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Background: Many transplant (tx) programs are reluctant to import pancreas allografts because of concerns that outcomes might be inferior to locally procured organs. Methods: Single…2015 American Transplant Congress
Simultaneous Cadaveric Pancreas, Living-Donor Kidney Transplantation: Single Center Experience
Surgery and Organ Transplant Center, Asan Medical Center, Seoul, Korea.
BackgroundSimultaneous cadaveric pancreas and living-donor kidney transplantation(SPLK) is an attractive approach for uremic Type I diabetic patients, due to its distinct advantages from living kidney…2015 American Transplant Congress
Longterm Outcome in Pancreas Grafts After Polyomavirus Infection in Combined Kidney-Pancreas Transplants: A Single Center Report
Purpose: We retrospectively analyzed the longterm survival and function in pancreas grafts after reduction of immunosuppression due to polyomavirus infection in simultaneous pancreas kidney transplants…2015 American Transplant Congress
Successful Consolidation of Two Kidney/Pancreas Transplant Programs
Renal & Pancreas Transplant, Barnabas Health, Livingston.
The decision to consolidate two kidney/pancreas transplant programs within the same healthcare system and within a 10 mile radius, was a pro-active approach in an…2015 American Transplant Congress
Long Term Follow Up Reveals Satisfactory Renal Outcome in Pacreas After Kidney Transplantation (PAK)
Objective: PAK offers diabetic ESRD patients' opportunity to avoid or minimize dialysis using living kidney donation, followed by cadaveric pancreas transplantation thereafter to restore euglycemia,…2015 American Transplant Congress
Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients
BackgroundBK virus (BKV) is a common infection in simultaneous pancreas-kidney (SPK) transplant recipients. Data in kidney transplant recipients suggest that immunosuppression regimens containing an mTORi…
American Transplant Congress abstracts